Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barre syndrome and multiple sclerosis

Journal of Neuroimmunology

Volumn 67, Issue 1, 1996, Pages 17-20

  Vedeler, C A ^a   Matre, R ^a   Sadallah, S ^b   Schifferli, J ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Complement receptor; Guillain Barre syndrome; Multiple sclerosis

Indexed keywords

COMPLEMENT RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0030176189     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00035-5     Document Type: Article

References (17)

1. Compston, D.A.S., Morgan, B.P., Campbell, A.K., Wilkins, P., Cole, G., Thomas, N.D. and Jasani, B. (1989) Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15, 307-316 .
2. Fearon, D.T. (1980) Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte. B lymphocyte, and monocyte. J. Exp. Med. 152, 20-30.
3. Fearon, D.T. (1979) Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 76, 5867-5871.
4. Iida, K, and Nussenzweig, V. (1981) Complement receptor is an inhibitor of the complement cascade. J. Exp. Med. 153, 1138-1150.
5. Koski, C.L., Sanders, M.E., Swoveland, P.T., Lawly, T.J., Shin, M.L., Frank, M.M. and Joiner, K.A. (1987) Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies. J. Clin. Invest. 80, 1492-1497.
6. Matre, R. and Tønder, O. (1976) Complement receptors in human renal glomeruli. Scand. J. Immunol. 5, 437-441.
7. Mollnes, T.E., Vandvik, B., Lea, T. and Vartdal, F. (1987) Intrathecal complement activation in neurological diseases evaluated by analysis of the terminal complement complex. J. Neurol. Sci. 78, 17-28.
8. Pascual, M., Duchosal, M.A., Steiger, G., Giostra, E., Pechere, A., Paccaud, J.P., Danielsson, C. and Schifferli, J.A. (1993) Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes. J. Immunol. 151, 1702-1711.
9. Pascual, M., Steiger, G., Sadallah, S., Paccaud, J.P., Carpentier, J.L., James, R., Schifferli, J.A. (1994) Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J. Exp. Med. 197, 889-899.
10. Piddlesden, S.J., Storch, M.K., Hibbs, M., Freeman, A.M., Lassmann, H. and Morgan, B.P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152, 5477-5484.
11. Roddy, J., Clark, I., Hazleman, B.L., Compston, D.A.S. and Scolding, N.J. (1994) Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders. J. Neurol. 241, 557-560.
12. Ropper, A.H. (1991) Guilluin-Barré syndrome. In: A.H. Ropper, E.F.M. Wijdicks and B.T. Truax (Eds.). Guillain-Barré syndrome. F.A. Davis Company, Philadelphia, p. 160.
13. Sanders, M.E., Koski, C.L., Robbins, D., Shin, M.L., Frank, M.M. and Joiner, K.A. (1986) Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis. J. Immunol. 136, 4456-4459.
14. Ulvestad, E., Williams, K., Bjerkvig, R., Tiekotter, K., Antel, J. and Matre, R. (1994) Human microglial cells have phenotypic and functional characteristics in common with both macrophages and antigen-presenting cells. J. Leuk. Biol. 56, 732-740.
15. Vedeler, C.A. and Matre, R. (1988) Complement receptors CR1 on human peripheral nerve fibres. J. Neuroimmunol. 17, 315-322.
16. Vedeler, C.A., Matre, R. and Nyland, H. (1986) Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome. Acta Neurol. Scand. 73, 388-393.
17. Yoon, S.H. and Fearon, D.T. (1985) Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol. 134, 3332-3338.